Novel FLT3/AURK multikinase inhibitor is efficacious against sorafenib-refractory and sorafenib-resistant hepatocellular carcinoma

por Lai, You-Liang, Wang, Kai-Hung, Hsieh, Hsing-Pang, Yen, Wan-Ching
Publicado 2022

RSPO3 antagonism inhibits growth and tumorigenicity in colorectal tumors harboring common Wnt pathway mutations

por Fischer, Marcus M., Yeung, V. Pete, Cattaruzza, Fiore, Hussein, Rajaa, Yen, Wan-Ching, Murriel, Christopher, Evans, James W., O’Young, Gilbert, Brunner, Alayne L., Wang, Min, Cain, Jennifer, Cancilla, Belinda, Kapoun, Ann, Hoey, Timothy
Publicado 2017

WNT antagonists exhibit unique combinatorial antitumor activity with taxanes by potentiating mitotic cell death

por Fischer, Marcus M., Cancilla, Belinda, Yeung, V. Pete, Cattaruzza, Fiore, Chartier, Cecile, Murriel, Christopher L., Cain, Jennifer, Tam, Raymond, Cheng, Chieh-Yang, Evans, James W., O’Young, Gilbert, Song, Xiaomei, Lewicki, John, Kapoun, Ann M., Gurney, Austin, Yen, Wan-Ching, Hoey, Timothy
Publicado 2017